Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: Protection by atorvastatin and pitavastatin

Neuroscience

Volumn 197, Issue , 2011, Pages 358-368

  Kurata, T ^a   Miyazaki, K ^a   Kozuki, M ^a   Morimoto, N ^a   Ohta, Y ^a   Ikeda, Y ^a   Abe, K ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Astrocyte; Collagen IV; Microglia; Neurovascular unit

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ATORVASTATIN; COLLAGEN TYPE 4; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; N ACETYL GLUCOSAMINE OLIGOMER; N ACETYLGLUCOSAMINE; PITAVASTATIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BASEMENT MEMBRANE; BRAIN BLOOD VESSEL; BRAIN CORTEX; CAPILLARY ENDOTHELIUM; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; MOUSE; NEUROPROTECTION; NEUROVASCULAR UNIT; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; VASCULAR ENDOTHELIUM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEPTANOIC ACIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; PYRROLES; QUINOLINES;

EID: 82855175132     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.09.030     Document Type: Article

References (50)

1. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
2. Asahina M., Yoshiyama Y., Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin Neuropathol 2001, 20:60-63.
3. Augustin H.G., Braun K., Telemenakis I., Modlich U., Kuhn W. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 1995, 147:339-351.
4. Backstrom J.R., Lim G.P., Cullen M.J., Tökés Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40). J Neurosci 1996, 16:7910-7919.
5. Bell R.D., Deane R., Chow N., Long X., Sagare A., Singh I., Streb J.W., Guo H., Rubio A., Van Nostrand W., Miano J.M., Zlokovic B.V. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 2009, 11:143-153.
6. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009, 118:103-113.
7. Bouras C., Kövari E., Herrmann F.R., Rivara C.B., Bailey T.L., von Gunten A., Hof P.R., Giannakopoulos P. Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol 2006, 65:235-244.
8. Bundgaard M., Abbott N.J. All vertebrates started out with a glial blood-brain barrier 4-500 million years ago. Glia 2008, 56:699-708.
9. Chow N., Bell R.D., Deane R., Streb J.W., Chen J., Brooks A., Van Nostrand W., Miano J.M., Zlokovic B.V. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A 2007, 104:823-828.
10. Coria F., Rubio I. Cerebral amyloid angiopathies. Neuropathol Appl Neurobiol 1996, 22:216-227.
11. Cullen K.M., Kócsi Z., Stone J. Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiol Aging 2006, 12:1786-1796.
12. Del Zoppo G.J. Bleeding in the brain: Amyloid-β may keep clots away. Nat Med 2009, 15:1132-1133.
13. Holmberg E., Zhang S.X., Sarmiere P.D., Kluge B.R., White J.T., Doolen S. Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system injury. Exp Neurol 2008, 214:78-86.
14. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
15. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004, 5:347-360.
16. Iadecola C., Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007, 10:1369-1376.
17. Jellinger K.A. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 2000, 203-204:153-157.
18. Kajinami K., Mabuchi H., Saito Y. NK-104: a novel synthetic HMG-CoA reductase inhibitor. Expert Opin Investig Drugs 2000, 9:2653-2661.
19. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001, 21:372-381.
20. Kitaguchi H., Ihara M., Saiki H., Takahashi R., Tomimoto H. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease. Neurosci Lett 2007, 417:128-131.
21. Kumar-Singh S., Pirici D., McGowan E., Serneels S., Ceuterick C., Hardy J., Duff K., Dickson D., Van Broeckhoven C. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol 2005, 167:527-543.
22. Kurata T., Kawarabayashi T., Murakami T., Miyazaki K., Morimoto N., Ohta Y., Takehisa Y., Nagai M., Ikeda M., Matsubara E., Westaway D., Hyslop P.S., Harigaya Y., Kamiya T., Shoji M., Abe K. Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1. J Neurosci Res 2007, 85:2246-2252.
23. Kurata T., Miyazaki K., Kozuki M., Panin V.L., Morimoto N., Ohta Y., Nagai M., Ikeda Y., Matsuura T., Abe K. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Brain Res 2011, 1371:161-170.
24. Lo E.H., Wang X., Cuzner M.L. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 2002, 69:1-9.
25. Mann G.E., Zlokovic B.V., Yudilevich D.L. Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. Biochim Biophys Acta 1985, 819:241-248.
26. Miyazaki K., Ohta Y., Nagai M., Morimoto N., Kurata T., Takehisa Y., Ikeda Y., Matsuura T., Abe K. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res 2011, 89:718-728.
27. Mulligan S.J., MacVicar B.A. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004, 431:195-199.
28. Narindrasorasak S., Altman R.A., Gonzalez-DeWhitt P., Greenberg B.D., Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab Invest 1995, 72:272-282.
29. Olabarria M., Noristani H.N., Verkhratsky A., Rodríguez J.J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010, 58:831-838.
30. Paris D., Patel N., DelleDonne A., Quadros A., Smeed R., Mullan M. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 2004, 366:80-85.
31. Pekny M., Wilhelmsson U., Bogestål Y.R., Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007, 82:95-111.
32. Perlmutter L.S., Barron E., Saperia D., Chui H.C. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J Neuro Res 1991, 30:673-681.
33. Petanceska S.S., DeRosa S., Olm V., Diaz N., Sharma A., Thomas-Bryant T., Duff K., Pappolla M., Refolo L.M. Statin therapy for Alzheimer's disease: will it work?. J Mol Neurosci 2002, 19:155-161.
34. Piermartiri T.C., Figueiredo C.P., Rial D., Duarte F.S., Bezerra S.C., Mancini G., de Bem A.F., Prediger R.D., Tasca C.I. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. Exp Neurol 2010, 226:274-284.
35. Porter K.E., Turner N.A. Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9. Biochem Soc Trans 2002, 30:120-126.
36. Ruitenberg A., den Heijer T., Bakker S.L., van Swieten J.C., Koudstaal P.J., Hofman A., Breteler M.M. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005, 57:789-794.
37. Shi J., Perry G., Smith M.A., Friedland R.P. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000, 21:357-361.
38. Suter O.C., Sunthorn T., Kraftsik R., Straubel J., Darekar P., Khalili K., Miklossy J. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002, 33:1986-1992.
39. Suzuki H., Aoki T., Tamaki T., Sato F., Kitahara M., Saito Y. Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs. Atherosclerosis 1999, 146:259-270.
40. Thirumangalakudi L., Samany P.G., Owoso A., Wiskar B., Grammas P. Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis 2006, 10:11-18.
41. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989, 180:487-502.
42. Turner D.C., Flier L.A., Carbonetto S. Magnesium-dependent attachment and neurite outgrowth by PC12 cells on collagen and laminin substrata. Dev Biol 1987, 121:510-525.
43. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348:1215-1222.
44. Wang C.X., Shuaib A. Critical role of microvasculature basal lamina in ischemic brain injury. Prog Neurobiol 2007, 83:140-148.
45. Wu Z., Guo H., Chow N., Sallstrom J., Bell R.D., Deane R., Brooks A.I., Kanagala S., Rubio A., Sagare A., Liu D., Li F., Armstrong D., Gasiewicz T., Zidovetzki R., Song X., Hofman F., Zlokovic B.V. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 2005, 11:959-965.
46. Yamashita T., Kamiya T., Deguchi K., Inaba T., Zhang H., Shang J., Miyazaki K., Ohtsuka A., Katayama Y., Abe K. Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab 2009, 29:715-725.
47. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
48. Zlokovic B.V., Segal M.B., Begley D.J., Davson H., Rakić L. Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. Brain Res 1985, 358:191-199.
49. Zlokovic B.V., Shinia Y., Holtzman D., Ghiso J., Frangione B. Clearance of β-amyloid from brain: transport or metabolism?. Nat Med 2000, 6:718-719.
50. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K.A., Pozzan T., Carmiqnoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003, 6:43-50.